We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIIB market cap is 30.31B. The company's latest EPS is USD 7.9877 and P/E is 26.15.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.54B | 2.46B | 2.46B | 2.53B | 2.39B |
| Operating Income | 556.7M | 507.7M | 643.8M | 44.8M | 775.7M |
| Net Income | 550.4M | 387.9M | 591.6M | -68.1M | 249.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.44B | 13.62B | 11.03B | 10.17B | 9.84B |
| Operating Income | 7.04B | 4.55B | 3.09B | 2.76B | 2.03B |
| Net Income | 5.89B | 4B | 1.81B | 3.05B | 1.16B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.55B | 24.6B | 25.16B | 28.19B | 26.84B |
| Total Liabilities | 11.17B | 10.81B | 10.7B | 13.71B | 12.05B |
| Total Equity | 13.39B | 13.79B | 14.46B | 14.48B | 14.8B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.23B | 24.62B | 23.88B | 24.55B | 26.84B |
| Total Liabilities | 13.9B | 13.93B | 12.92B | 11.17B | 12.05B |
| Total Equity | 13.34B | 10.69B | 10.96B | 13.39B | 14.8B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.38B | 455.3M | 942.3M | 1.53B | 1.55B |
| Investing | 1.58B | -953M | -1.71B | -3.45B | -4.1B |
| Financing | -1.75B | -43.4M | -53.2M | 795.4M | 149.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.08B | 4.23B | 3.64B | 1.38B | 1.55B |
| Investing | 470.5M | -608.6M | -563.7M | 1.58B | -4.1B |
| Financing | -5.86B | -5.27B | -2.09B | -1.75B | 149.3M |
| Market Cap | 30.31B |
| Price to Earnings Ratio | 26.15 |
| Price to Sales Ratio | 3.09 |
| Price to Cash Ratio | 28.92 |
| Price to Book Ratio | 2.05 |
| Dividend Yield | - |
| Shares Outstanding | 145.36M |
| Average Volume (1 week) | 1.8M |
| Average Volume (1 Month) | 1.24M |
| 52 Week Change | -25.16% |
| 52 Week High | 319.76 |
| 52 Week Low | 189.44 |
| Spread (Intraday) | 1.15 (0.55%) |
| Company Name | Biogen Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.biogen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
